Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Apple
AAPL
|
+$619M |
| 2 |
Microsoft
MSFT
|
+$486M |
| 3 |
Broadcom
AVGO
|
+$479M |
| 4 |
Cisco
CSCO
|
+$238M |
| 5 |
Meta Platforms (Facebook)
META
|
+$235M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$450M |
| 2 |
VMW
VMware, Inc
VMW
|
+$293M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$189M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$168M |
| 5 |
Danaher
DHR
|
+$135M |
Sector Composition
| 1 | Technology | 29.63% |
| 2 | Healthcare | 12.35% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PKST
2301
Peakstone Realty Trust
PKST
$506M
| $757K | ﹤0.01% |
37,994
| – | – |
|
|
RDUS
2302
DELISTED
Radius Recycling
RDUS
| $756K | ﹤0.01% |
25,077
-1,535
| -6% | -$46.3K |
|
2303
Pliant Therapeutics
PLRX
$101M
| $756K | ﹤0.01% |
41,734
-184
| -0.4% | -$3.33K |
|
2304
Integral Ad Science
IAS
$1.44B
| $755K | ﹤0.01% |
52,478
+4,121
| +9% | +$59.3K |
|
2305
Driven Brands
DRVN
$3.05B
| $753K | ﹤0.01% |
52,833
-282
| -0.5% | -$4.02K |
|
2306
Viridian Therapeutics
VRDN
$1.6B
| $753K | ﹤0.01% |
34,566
+7,206
| +26% | +$157K |
|
2307
Keros Therapeutics
KROS
$640M
| $751K | ﹤0.01% |
18,876
-50
| -0.3% | -$1.99K |
|
2308
QCR Holdings
QCRH
$1.32B
| $746K | ﹤0.01% |
12,775
+342
| +3% | +$20K |
|
2309
Maravai LifeSciences
MRVI
$404M
| $741K | ﹤0.01% |
113,063
| – | – |
|
2310
Univest Financial
UVSP
$901M
| $740K | ﹤0.01% |
33,581
| – | – |
|
2311
Garrett Motion
GTX
$2.69B
| $740K | ﹤0.01% |
76,501
| – | – |
|
2312
Vita Coco
COCO
$2.22B
| $738K | ﹤0.01% |
28,770
-792
| -3% | -$20.3K |
|
2313
CryoPort
CYRX
$474M
| $737K | ﹤0.01% |
47,590
+280
| +0.6% | +$4.34K |
|
2314
Ultrapar
UGP
$4.05B
| $735K | ﹤0.01% |
135,500
| – | – |
|
2315
Kimbell Royalty Partners
KRP
$1.28B
| $734K | ﹤0.01% |
48,785
| – | – |
|
|
RVNC
2316
DELISTED
Revance Therapeutics, Inc.
RVNC
| $734K | ﹤0.01% |
83,463
+163
| +0.2% | +$1.43K |
|
|
INBX
2317
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $732K | ﹤0.01% |
19,265
-2,896
| -13% | -$110K |
|
2318
Amplitude
AMPL
$1.5B
| $729K | ﹤0.01% |
57,293
+2,739
| +5% | +$34.8K |
|
2319
Center Bancorp
CNOB
$1.27B
| $728K | ﹤0.01% |
31,788
+1,948
| +7% | +$44.6K |
|
2320
IMAX
IMAX
$1.71B
| $724K | ﹤0.01% |
48,197
+1,066
| +2% | +$16K |
|
2321
Open Lending Corp
LPRO
$260M
| $724K | ﹤0.01% |
85,047
+2,601
| +3% | +$22.1K |
|
|
DCBO
2322
Docebo
DCBO
$867M
| $722K | ﹤0.01% |
14,881
-176
| -1% | -$8.54K |
|
|
VERV
2323
DELISTED
Verve Therapeutics
VERV
| $721K | ﹤0.01% |
51,730
+12,880
| +33% | +$180K |
|
2324
Life Time Group Holdings
LTH
$6.46B
| $717K | ﹤0.01% |
47,548
| – | – |
|
2325
Revolve Group
RVLV
$1.71B
| $717K | ﹤0.01% |
43,229
+1,659
| +4% | +$27.5K |
|